Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 10

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 3
Chunk 10
---
er, as defined in the Securities
Exchange Act of 1934, as amended, (the “ Exchange Act”) or (4) the date on which we have issued more than $1.0 billion in
non-convertible debt during the prior three-year period.

In
addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those
standards apply to private companies. The Company has elected to avail itself of this exemption from new or revised accounting standards
and, therefore, the Company will not be subject to the same new or revised accounting standards as other public companies that are not
emerging growth companies.

Even
after the Company no longer qualifies as an emerging growth company, it may still qualify as a “smaller reporting company,”
which would allow it to take advantage of many of the same exemptions from disclosure requirements including exemption from compliance
with the auditor attestation requirements of Section 404 and reduced disclosure obligations regarding executive compensation in this
proxy statement and the Company’s periodic reports and proxy statements.

The
Company cannot predict if investors will find its ordinary shares less attractive because the Company may rely on these exemptions. If
some investors find the Company’s ordinary shares less attractive as a result, there may be a less active trading market for the
ordinary shares and its market price may be more volatile.

   7  

Because
of the Company’s public float, the impact of the actions taken by a few shareholders on the price of its ordinary shares may be
amplified by the Company’s public float, and such price volatility may make it difficult for prospective investors to assess the
value of the Company’s ordinary shares.

The
Company’s ordinary shares may be subject to extreme volatility that is seemingly unrelated to the underlying performance of its
business. Recently, companies with comparable public floats and public offering sizes have experienced instances of extreme stock price
run-ups followed by rapid price declines, and such stock price volatility was seemingly unrelated to the respective company’s underlying
performance. Although the specific cause of such volatility is unclear, the Company’s public float may amplify the impact of the
actions taken by a few shareholders on the price of its ordinary shares, which may cause its share price to deviate, potentially significantly,
from a price that better reflects the underlying performance of its business. Should the Company’s ordinary shares experience run-ups
and declines that are seemingly unrelated to the Company’s actual or expected operating performance and financial condition or
prospects, prospective